Xander Bogaerts

All-Star Futures Game wrap: U.S. beats World 4-2

5 Comments

Not that the score really matters, but the U.S. team topped the World squad in the All-Star Futures Game again this year, winning 4-2 and outhitting the competition 9-3. Of course, this game is more fun to watch for the individual performances that any sort of team effort. So, let’s get right to the prospects who shined and those that fell flat:

The standouts

– Xander Bogaerts (SS Red Sox): The world team’s best prospect, Bogaerts singled back up the middle in each of his first two at-bats and walked in the fourth. In the first, he fouled off a two-strike slider from Noah Syndergaard and then grounded a 96-mph heater back through the box. He was caught stealing in the first, mostly because of an odd slide that caused him to miss the bag with his front leg. He showed much better instincts in the fourth, when he raced home on a sac fly and evaded the catcher’s tag by going inside the baseline and hooking around it.

– Eddie Butler (RHP Rockies): The 22-year-old Butler turned in the most impressive inning of the game, even if he did allow a single before getting a double play. He topped out at 98 mph with his fastball, and he struck out Bogaerts on three pitches, including a 90-mph changeup with lethal movement down and in to the right-handed hitter. There are questions about how Butler will hold up as a starter, but he could probably help the Rockies as a reliever right now if they want to go that route.

– Arismendy Alcantara (2B Cubs): Showing his emerging power, Alcantara pulled an Anthony Ranaudo fastball into the second deck at Citi Field. Alcantara has 13 homers in 389 at-bats in Double-A this year after hitting seven in 359 at-bats in the FSL last year and two in 390 at-bats in the Midwest League in 2011. The Cubs just recently moved him from shortstop to second base to make room for Javier Baez on the Smokies. He’s always profiled better there anywhere, and he could be the team’s replacement for Darwin Barney next summer or in 2015.

– Christian Yelich (OF Marlins): A couple of other guys might have more potential, but Yelich is the best hitter, as of July 14, 2013, of anyone who was playing today. He showed it by doubling over center fielder Gregory Polanco’s head in his first at-bat and singling in his second. The Marlins might make room for him in the outfield soon by trading Justin Ruggiano.

– Jesse Biddle (LHP Phillies): It was a tough call whether Biddle or Archie Bradley showed the best curve of the day. Biddle’s is reminiscent of Barry Zito’s, and while he doesn’t have the ceiling of a Bradley or a Taijuan Walker, he doesn’t lack for polish. He stranded two runners in the fifth, and he was the one pitcher to get four outs today.

– Rafael Montero (RHP Mets): With the game being played at Citi Field, the Mets had the starting pitchers for both sides today, with Montero going for the World team and Syndergaard pitching for the U.S. Montero needed just nine pitches in his inning of work, but he still managed to mix in a couple of nice sliders.

The disappointments

– Michael Ynoa (RHP Athletics): After battling injuries, Ynoa, one of the biggest Latin American signings ever, broke through in the Midwest League this year, posting a 2.14 ERA in 15 starts (54 2/3 innings) for Beloit. However, he’s given up 11 earned runs in 7 2/3 innings since moving up to the California League and he didn’t impressive with his command or stuff today. He gave up a two-run homer to the Diamondbacks’ Matt Davidson in his inning of work.

– Reymond Fuentes (OF Padres): Fuentes was the World Team’s leadoff man because of his .412 OBP in Double-A this year, but he made first-pitch outs in two of his three at-bats today. One was a routine fly to center and the other was a pop to shortstop. Fuentes did have a better at-bat in between, battling back from an 0-2 count to eventually ground out on Archie Bradley’s seventh pitch.

– Byron Buxton (OF Twins): It was more a disappointment for us watching than any reflection on Buxton as a prospect, but Buxton saw 11 pitches today, swung at three and made contact just once, hitting a foul ball. He struck out swinging in both of his appearances.

– Henry Urrutia (OF Orioles): Some think the 26-year-old Urrutia, a Cuban defector in his first year in the minors, could come up and help the Orioles down the stretch, but he didn’t show much today. He grounded out in each of his first three at-bats, with the third going for a double play, before drawing a four-pitch walk from a wild Kyle Crick his last time up. Maybe that shouldn’t overshadow the fact that he’s hit .365/.427/.531 in the minors this year, but his tools aren’t all that impressive.

– Addison Russell (SS Athletics): I think Russell is a tremendous prospect, but he was overmatched at the plate today, particularly in his first at-bat against Enny Romero, when he went down swinging at a slider off the plate. He was also Ynoa’s lone strikeout victim. Russell, though, is just 19. He may well be back as the U.S. team’s starting shortstop in this game again next year.

Marlins acquire starter Dan Straily from the Reds

CINCINNATI, OH - SEPTEMBER 3: Dan Straily #58 of the Cincinnati Reds throws a pitch during the first inning of the game against the St. Louis Cardinals at Great American Ball Park on September 3, 2016 in Cincinnati, Ohio. (Photo by John Sommers II/Getty Images)
Getty Images
1 Comment

The Miami Marlins have acquired starting pitcher Dan Straily from the Cincinnati Reds. In exchange, the Reds will receive right-handed pitching prospects Luis Castillo and Austin Brice and outfield prospect Isaiah White.

For the Marlins, they get a solid starter who logged 191.1 innings of 113 ERA+ ball last year. Straily has moved around a lot in his five big league seasons — the Marlins will be his fifth club in six years — but it was something of a breakout year for him in Cincinnati. The only troubling thing: he tied for the league lead in homers allowed. Of course, pitching half of his games in Great American Ballpark didn’t help that, and Miami will be a better place for him.

Castillo is 24. He split last season between high-A and Double-A — far more of it in A-ball — posting a 2.26 ERA over 24 starts. Austin Brice is also 24. He pitched 15 games in relief for the Marlins last year at the big league level with poor results. He seemed to blossom at Triple-A, however, after the Marlins shifted him to the pen. White was a third round pick in the 2015 draft. He played low-A ball as a minor leaguer last year, hitting .214/.306/.301.

A mixed bag of young talent for the Reds, but stockpiling kids and seeing what shakes out is what a team like the Reds should be doing at the moment. For the Marlins: a solid mid-to-back end starter who may just be coming into his own.

Have Hall of Fame Voters actually made the PED thing More complicated?

Sammy Sosa
Associated Press
22 Comments

The story coming out of this year’s Hall of Fame balloting is that the BBWAA voters are finally easing their antipathy toward players with performance enhancing drug associations.

Jeff Bagwell — the subject of unconfirmed PED rumors — made the Hall! Pudge Rodriguez, who was named in Jose Canseco’s book and who had a . . . curious physical transformation around the time PED testing came online, made it on the first ballot! Barry Bonds and Roger Clemens, whose PED use was well-documented, saw their vote totals advance above the 50% mark, making their future elections look more likely!

It’s an interesting development, and one I’m obviously pleased with, but I wonder if the BBWAA’s new approach to PED guys, while far more forgiving than it used to be, has actually become more complicated in practice.

I ask this because I look way, way down the ballot and I still see Sammy Sosa scraping by with around 8% of the vote. I ask this because I still see Gary Sheffield at 13%. I ask this because when Mark McGwire was on the Today’s Game ballot in December, no one really stumped for him at all. I ask this because, even though Bagwell and Mike Piazza got in eventually, they still had to go through a lot of hazing first and I suspect, if they hit the ballot for the first time again tomorrow, the same arguments and delay would occur with respect to their cases.

In light of that, what I suspect has happened has not been a wholesale surrender of the anti-PED voters. Rather, I think it has been a transformation. One in which a moral test — did he use PEDs or not? — has been discarded as a threshold question and a scientific/physiological test — would he have been great even without the PEDs? — has replaced it. In essence, voters are becoming “PED discounters” in the aggregate. Making calculations as to whether a guy was, in their mind, a creation of PEDs or not.

Such an approach explains these new voting patterns as well as those in recent years.

  • Ivan Rodriguez may have been called out by Canseco and may have noticeably shrunk over an offseason, but his calling card was his defense behind the plate and voters, I suspect, have told themselves that such a thing is not PED-aided.
  • Bonds and Clemens may have been PED users, but each of them was undeniably talented and, if you discount for the PED use, hey, they’re still all-time greats.
  • Sammy Sosa’s case rests disproportionately on homers and, as everyone knows, PEDs = instant dingers, so no, he’s not gonna cut it.

And so on.

As I said, I’m glad that the strict moral test — did he use or not? — is losing its hold on Hall voters. But I do not think the “did PEDs make him who he was test?” is a good approach either. Baseball writers are in no better a position to assess the physiological and performance enhancements caused by pharmaceuticals than they are to be judges of character and morality. Given the identities of players confirmed to be PED users, the old eye test implicit in these cases is famously faulty (Neifi Perez, anyone?). The idea that PEDs only affect home run totals — and not, say, the ability for a player to take the abuse of the catcher position for 21 seasons — is crude and ignorant.

I suppose it’s naive to expect voters to completely disregard PEDs in their assessment of players. It’s a bell that cannot be unrung. But while we may, thankfully, be moving away from a moral test with respect to drugs, it’s been displaced by a scientific test that is no more reasonable in practice.